Tag: impath inc

Dynacare, LabCorp, IMPATH, Visible Genetics, Abbott Labs

With Quest Diagnostics Incorporated snapping up independent lab companies right and left in recent months, the question asked by many is “Where’s Laboratory Corporation of America?”

On the sell side, American Medical Laboratories and Unilab have been acquired by Quest Diagnostics. The largest remaining independent commercial

View Article

Park City Solutions, DIANON, IMPATH American Med Labs, Cytyc, TriPath Imaging

TWO COMPANIES FINANCED by GTCR Golder Rauner, LLC, the private equity firm based in Chicago, announced a strategic relationship.

Park City Solutions, Inc. of Park City, Utah and American Medical Laboratories, Inc. (AML) of Chantilly, Virginia will work together to develop e-business services for healthcare, with a

View Article

Developing Technology Expected To Fuel Boom In Anatomic Pathology

CEO SUMMARY: Established demographic trends point to a coming boom in the demand for anatomic pathology services. Greater number s of senior citizens, living longer lives, will raise the number of cancer cases diagnosed annually in the United States. New diagnostic technology will increase the value of the pathologist to clinicians. But before a pathology

View Article

IMPATH Points Pathology Toward a Winning Future

CEO SUMMARY: Pathology is about to undergo a market transformation similar to radiology. As clinicians insist on more precise diagnostic and prognostic information about their patients, pathologists will have a perfect opportunity to reposition themselves as essential partners with the referring physician. IMPATH points the way, but there is room for many other pathologists to

View Article

IMPATH Creates Its Brand Of Value-Added Pathology

CEO SUMMARY: IMPATH Inc. is a pathology company with an interesting twist. It doesn’t compete directly with community hospital-based pathologists like some national AP providers. Instead, it offers AP services which supplement the capabilities of the local pathologist. The formula must work. During IMPATH’s short life, it has grown rapidly. Revenues are up, profits are

View Article

“Disease Management” Firms, Niche Labs Release Financials

Two DISEASE MANAGEMENT FIRMS enjoyed strong revenue growth during the first quarter of 1998. UroCor, Inc. and Impath Inc. posted revenue increases of 31% and 49%, respectively, over first quarter 1997.

UroCor is the disease management company which serves urologists throughout the United States. The company’s first quarter financial performance showed strong revenue growth but reduced

View Article

“March 23, 1998 Intelligence: Late Breaking Lab News”

Independent physician association (IPA) executives gathered in Orlando two weeks ago for the annual meeting of TIPAAA, The IPA Association of America. Because IPAs play an increasing role in contracting for laboratory services, THE DARK REPORT was in attendance to learn more about this phenomenon. Over 1,000 people showed up for the meeting.

IPAs are

View Article